ArticleVaccines2025
Immunomodulation of Patients with Canine Visceral Leishmaniasis at Different Stages: A 12-Month Follow-Up Study Using LaSap.
Kelvinson Fernandes Viana, Adrieli Barboza de Souza, Sara Torres, Maria Camila Escobar Garcia, Açucena Veleh Rivas, Alex Sander Rodrigues Cangussu, Francisca Hildemagna Guedes da Silva, Rodolfo Cordeiro Giunchetti
Abstract read
In one paragraphArticle in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Kelvinson Fernandes VianaVaccine Development Technology Laboratory, Federal University for Latin American Integration (UNILA), Foz do Iguaçu 85870-650, PR, Brazil.ORCID 0000-0002-4657-5446 Adrieli Barboza de SouzaVaccine Development Technology Laboratory, Federal University for Latin American Integration (UNILA), Foz do Iguaçu 85870-650, PR, Brazil.
Sara TorresVaccine Development Technology Laboratory, Federal University for Latin American Integration (UNILA), Foz do Iguaçu 85870-650, PR, Brazil.
Maria Camila Escobar GarciaVaccine Development Technology Laboratory, Federal University for Latin American Integration (UNILA), Foz do Iguaçu 85870-650, PR, Brazil.
Açucena Veleh RivasVaccine Development Technology Laboratory, Federal University for Latin American Integration (UNILA), Foz do Iguaçu 85870-650, PR, Brazil.ORCID 0000-0001-5960-101X Alex Sander Rodrigues CangussuVaccine Laboratory, Federal University of Tocantins (UFT), Gurupi 77410-530, TO, Brazil.
Francisca Hildemagna Guedes da SilvaLeopoldo de Meis Institute of Medical Biochemistry, National Institute of Science and Technology for Structural Biology and Bioimaging, National Center of Nuclear Magnetic Resonance Jiri Jonas, Federal University of Rio de Janeiro, Rio de Janeiro 21941-599, RJ, Brazil.
Rodolfo Cordeiro GiunchettiCellular Interaction Biology Laboratory, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte 31270-901, MG, Brazil.ORCID 0000-0003-4181-7546 Funding
Unila 105/2020
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
canine visceral leishmaniasisimmunotherapyLaSap
Identifiers
PMID41012136
PMCPMC12474320
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390